Chiglitazar

DB19023InvestigationalSmall molecule

Chiglitazar is under investigation in clinical trial NCT06125587 (Chiglitazar/metformin in Non-obese Women With PCOS).

Chemical structure of Chiglitazar
Mechanism
Curator reviewed
Formula / weight
C36H29FN2O4 · 572.636 g/mol (avg)
Also known as
(2s)-3-(4-(2-carbazol-9-ylethoxy)phenyl)-2-(2-(4-fluorobenzoyl)anilino)propanoic acid · Carfloglitazar, (s)- · L-tyrosine, o-(2-(9h-carbazol-9-yl)ethyl)-n-(2-(4-fluorobenzoyl)phenyl)- · O-(2-(9h-carbazol-9-yl)ethyl)-n-(2-(4-fluorobenzoyl)phenyl)-l-tyrosine
Code names
CS-038

Resolves to

Compound
UNIIE6EJV1J6Y0CAS743438-45-1ChEMBLCHEMBL4650349
Structure
InChIKeyQNLWMPLUWMWDMQ-YTTGMZPUSA-NSMILESOC(=O)[C@H](CC1=CC=C(OCCN2C3=C(C=CC=C3)C3=C2C=CC=C3)C=C1)NC1=CC=CC=C1C(=O)C1=CC=C(F)C=C1
Targets
Q07869PPARAP37231PPARG

What you can answer from here — as of September 05, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
17Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Chiglitazar, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In